PTK6 and breast cancer: Additionally, Breast Tumour Kinase (BRK), a non-receptor type tyrosine kinase, has been found to confer resistance to tamoxifen treatment in breast cancer through the regulation of CDK1 tyrosine phosphorylation (187).